SeaStar Medical Holding Corp Ordinary Shares ICU
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $3.17
- Day Range
- $3.11–3.29
- 52-Week Range
- $2.07–12.50
- Bid/Ask
- $3.10 / $3.24
- Shares Outstanding
- 4.00M
- Market Cap
- $12.71M
- Volume/Avg
- 58,844 / 92,473
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 6.64
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 17
- Website
- https://www.seastarmedical.com
Valuation
|
Metric
|
ICU
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.96 |
Price/Sales | 6.64 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ICU
|
|---|---|
Quick Ratio | 1.65 |
Current Ratio | 1.89 |
Interest Coverage | −518.11 |
Quick Ratio
ICU
Profitability
|
Metric
|
ICU
|
|---|---|
Return on Assets (Normalized) | −115.11% |
Return on Equity (Normalized) | −181.21% |
Return on Invested Capital (Normalized) | −180.28% |
Return on Assets
ICU
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|PD?CD& | LOCK|gywQY | $128B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|Y#LcRsb | LOCK|%Wj!x | $83B | |||
| argenx SE ADR
ARGX
| LOCK|#dMGR# | LOCK|G@h | $53B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|%&S<Nn%m | LOCK|$#^C | $51B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|Ykb&%h | LOCK|Bg# | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|#HRn^? | LOCK|>^#W | $31B | |||
| Moderna Inc
MRNA
| LOCK|<&$&tg | LOCK|fx# | $25B | |||
| Incyte Corp
INCY
| LOCK|Jn#JQVs | LOCK|WS | $24B | |||
| BioNTech SE ADR
BNTX
| LOCK|?h@Wh#r | LOCK|$f> | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|DB%?T%z | LOCK|G# | $16B |
United States